Greg Brophy: Chief Executive Officer
Mr. Brophy has served in a number of diverse operating roles including executive officer roles in two public companies (NYSE & NASDAQ), president of four distinct business groups, and head of business development with significant M&A and corporate finance experience. Operating roles have been in the medical device, biomedical, and healthcare services sectors, with experience ranging from a dynamic high growth environment to division turnaround responsibilities in connection with the break up of a public company. Mr. Brophy holds a BS in Electrical Engineering from the University of Notre Dame, a JD from the University of Georgia School of Law, and an MBA from the MIT Sloan School of Management.
John Joyoprayitno: President & Chief Operating Officer, Co-founder
Mr. Joyoprayitno oversees general operations, business development, sales, and distribution. Mr. Joyoprayitno has over 15 years of entrepreneurial experience founding, launching, growing, and managing companies ranging from medical, distribution, automotive, to consulting (medical, utility, technology, recreation). Mr. Joyoprayitno earned an MS in Technology Commercialization from the McCombs School of Business at UT-Austin.
Sarah Mayes, PhD, RAC: Chief Scientific Officer, Co-founder
Dr. Mayes is a co-inventor of the Alafair technology and holds several patents in the material science field. Dr. Mayes oversees clinical, R&D, QA/RA, product development, and manufacturing activities. Dr. Mayes earned a PhD in biomedical engineering from UT-Austin. She earned an MS in material science & engineering from The University of Michigan, Ann Arbor.
Ben Walthall, PhD: Chief Regulatory Officer
Dr. Walthall brings over 30 years of varied experience in new technology and product development. He is the author of numerous peer-reviewed articles and holds several patents in the biomedical field. Prior to joining Alafair, Dr. Walthall served as VP of R&D for Zimmer Biologics where he was responsible for directing biologic and drug delivery R&D in areas such as bone healing, spinal disc regeneration, restoration of soft tissue function, and cartilage repair. He has previously held senior positions in a variety of medical device companies managing technology strategies, portfolio management, and PD. Dr. Walthall earned a PhD in biochemistry from The University of Texas at Austin.
Bhushan Holay: VP of Finance
Mr. Holay has worked in the medical device industry for over a decade, with experience in research, product development, project management, and marketing. Prior to Alafair, he led the product development and commercialization efforts at Zimmer, Inc developing several commercially available implant biologics. Mr. Holay earned an MBA from The McCombs School of Business at The University of Texas at Austin and an MS in Chemical Engineering from Syracuse University.
Alex Shaevitz: VP of Sales
Mr. Shaevitz brings over twenty years of combined clinical and sales experience in the orthopedic industry with specialization in trauma, foot & ankle, upper extremity, and nerve repair. Mr. Shaevitz has contributed to the advancement of lower limb deformity correction with multiple co-inventions. Mr. Shaevitz represented Acumed as an agent for sixteen years and was the Co-founder and President of Quantum Medical Concepts. Mr. Shaevitz earned his MBA from Babson College in Wellesley, Massachusetts.
Emily Cheek: Territory Specialist
Ms. Cheek brings over eight years of experience in clinical support, education, and medical device sales with specialization in orthopedics. Ms. Cheek earned a BS in Communications at Loyola Marymount University in Los Angeles, CA where she competed as a 4-year NCAA indoor and beach volleyball player.